About Genomadix
Genomadix is a Healthcare company based in Ottawa (Canada) founded in 2021. Developer of a portable molecular analyzer for diagnostic purposes. Its chief executive, as recorded, is Steve Edgett. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Instrument Systems.
Company details
Genomadix was founded in 2021 in Ottawa, Canada, within the biotechnology sector focused on diagnostics. A portable device called the Genomadix Cube is developed to perform polymerase chain reaction (PCR) tests. Increased fluorescence is detected by the analyzer, and test results are automatically generated. Applications include identification of COVID-19 and various bacterial strains, supporting on-site molecular analysis in healthcare settings.
- Headquarters Ottawa, Canada
- SectorsHealthcare
- Phone•••• ••••
- Website genomadix.com
- Social LinkedIn
- InvestorsMayo Clinic
& 1 more
Funding Insights of Genomadix
- Total Rounds 2
- Investors Count 2
All 2 funding rounds of Genomadix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2022 | Seed | – | Mayo Clinic | – | |
| Jul 2022 | Seed | – | – |
2 investors in total: 2 institutional.
Investors in Genomadix
Genomadix has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Mayo Clinic and ICW Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Game-changing health technologies are developed by ICW Ventures. | icw.ventures | New York, United States | ||
General medical clinics are operated throughout the United States. | 1864 | mayoclinic.org | United States |
Investor details for Genomadix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Genomadix
1 people are tracked at Genomadix (1 in leadership).
| Name | Role | Group |
|---|---|---|
Steve Edgett | CEO | Leadership |
Complete people profiles for Genomadix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Genomadix
3 dated milestones of Genomadix across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Genomadix is founded.
- Funding First funding round.
- Funding Latest funding round, Seed,.
Web traffic of Genomadix
The website of Genomadix (genomadix.com) receives about 1.8K visits a month.
- Monthly visits1.8K
▲ 93.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genomadix
Complete news archive for Genomadix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genomadix
Genomadix was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Genomadix is headquartered in Ottawa, Canada. It is registered at Ottawa, Ontario, Canada.
Steve Edgett is the CEO of Genomadix, as recorded in our data.
Genomadix was founded in 2021 in Ottawa, Canada, within the biotechnology sector focused on diagnostics. A portable device called the Genomadix Cube is developed to perform polymerase chain reaction (PCR) tests. Increased fluorescence is detected by the analyzer, and test results are automatically generated. Applications include identification of COVID-19 and various bacterial strains, supporting on-site molecular analysis in healthcare settings.
Genomadix has 2 investors. Key investors include Mayo Clinic, and ICW Ventures.